Takeda Pharmaceutical Co., Asia’s largest drugmaker, is in talks to acquire closely held Swiss competitor Nycomed, said three people with knowledge of the situation.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.